Oclacitinib Patent Expiration
About Veterinary Oclacitinib
Oclacitinib is used in a drug marketed by 1 company: Zoetis Inc.
Other drugs containing Oclacitinib are: Apoquel chewable , Apoquel .
Veterinary Oclacitinib Patents
Given below is the list of patents protecting Oclacitinib, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Apoquel Chewable | US8987283 | 30 Jun, 2031 | ZOETIS INC. |
| Apoquel Chewable | US8133899 | 09 Apr, 2030 | ZOETIS INC. |
| Apoquel | US8133899 | 09 Apr, 2030 | ZOETIS INC. |
| Apoquel | US6890929 | 31 Jul, 2022 | ZOETIS INC. |
| Apoquel | US7687507 | 17 Jun, 2019 | ZOETIS INC. |
Oclacitinib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List